Filing metadata

Accession number
0001415889-21-001852
Form type
Form 3
Filer
Eloxx Pharmaceuticals, Inc.
CIK
CIK 1035354
Filed
Apr 02, 2021
Reporting period
Apr 01, 2021
Description
Initial ownership

Explore SEC Filings Hub